Academic outcomes in Asian children aged 8–11 years with attention-deficit/hyperactivity disorder treated with atomoxetine hydrochloride

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International journal of psychiatry in clinical practice

• Publication date

  2011-05-05

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3109/13651501.2010.550688PMID 22121863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Atomoxetine on Executive Function Impairments in Adults With ADHD

  2011cited by this paper
• A Randomized, Open-Label Assessment of Response to Various Doses of Atomoxetine in Korean Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder

  2011cited by this paper
• Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.

  2009cited by this paper
• Atomoxetine

  2009cited by this paper
• Positive Association Between Attention-Deficit/ Hyperactivity Disorder Medication Use and Academic Achievement During Elementary School

  2009cited by this paper
• Executive Function in Adolescence Among Children With Attention-Deficit/Hyperactivity Disorder in Taiwan

  2009cited by this paper
• Atomoxetine Treatment in Adolescents with Attention-Deficit/Hyperactivity Disorder

  2009cited by this paper
• Enhancing academic achievement for children with Attention-Deficit Hyperactivity Disorder: evidence from school-based intervention research.

  2008cited by this paper
• Long-Term School Outcomes for Children with Attention-Deficit/Hyperactivity Disorder: A Population-Based Perspective

  2007cited by this paper
• Academic and educational outcomes of children with ADHD.

  2007cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on Once-Daily Atomoxetine Hydrochloride in Taiwanese Children and Adolescents with Attention-Deficit/Hyperactivity Disorder

  2007cited by this paper
• Atomoxetine versus Methylphenidate in Paediatric Outpatients with Attention Deficit Hyperactivity Disorder: A Randomized, Double-Blind Comparison Trial

  2007cited by this paper
• A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.

  2007cited by this paper
• Atomoxetine Hydrochloride and Executive Function in Children with Attention-Deficit/Hyperactivity Disorder

  2005cited by this paper
• National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder.

  2004cited by this paper
• Impact of executive function deficits and attention-deficit/hyperactivity disorder (ADHD) on academic outcomes in children.

  2004cited by this paper
• Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.

  2002cited by this paper
• Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat: A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder

  2002cited by this paper
• Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory

  2001cited by this paper
• Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD.

  2001cited by this paper
• Inattention, hyperactivity and impulsiveness: their impact on academic achievement and progress.

  2001cited by this paper
• Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children

  1999cited by this paper
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

  1999cited by this paper
• The Revised Conners' Parent Rating Scale (CPRS-R): Factor Structure, Reliability, and Criterion Validity

  1998cited by this paper
• Effects of Stimulant Medication on Learning in Children with ADHD

  1991cited by this paper

• Capillary electrophoresis coupled with electrochemiluminescence for determination of atomoxetine hydrochloride and the study on its interactions with three proteins.

  2015cites this paper
• The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research

  2015cites this paper
• The Efficacy of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Clinical Research

  2015cites this paper
• Consequences of ADHD medication use for children's outcomes.

  2014cites this paper
• Assessment of ADHD

  2013cites this paper
• Future Directions for Practice and Research

  2013cites this paper
• ADHD in Adolescents (Middle and High School)

  2013cites this paper
• Efficacy and Safety of Atomoxetine in the Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder

  2012cites this paper
• The Effects of Pharmacological Treatment of ADHD on Children's Health

  2012cites this paper